Below are the most recent publications written about "Organs at Risk" by people in Profiles.
-
Choi HJ, Park H, Shin WG, Kim JI, Min CH. Development of a Geant4-based independent patient dose validation system with an elaborate multileaf collimator simulation model. J Appl Clin Med Phys. 2019 Feb; 20(2):94-106.
-
Abouegylah M, Braunstein LZ, Alm El-Din MA, Niemierko A, Salama L, Elebrashi M, Edgington SK, Remillard K, Napolitano B, Naoum GE, Sayegh HE, Gillespie T, Farouk M, Ismail AA, Taghian AG. Evaluation of radiation-induced cardiac toxicity in breast cancer patients treated with Trastuzumab-based chemotherapy. Breast Cancer Res Treat. 2019 Feb; 174(1):179-185.
-
Samadi K, Arellano RS. Ureteral protection during microwave ablation of renal cell carcinoma: combined use of pyeloperfusion and hydrodissection. Diagn Interv Radiol. 2018 Nov; 24(6):388-391.
-
den Otter LA, Kaza E, Kierkels RGJ, Meijers A, Ubbels FJF, Leach MO, Collins DJ, Langendijk JA, Knopf AC. Reproducibility of the lung anatomy under active breathing coordinator control: Dosimetric consequences for scanned proton treatments. Med Phys. 2018 Dec; 45(12):5525-5534.
-
Yang J, Veeraraghavan H, Armato SG, Farahani K, Kirby JS, Kalpathy-Kramer J, van Elmpt W, Dekker A, Han X, Feng X, Aljabar P, Oliveira B, van der Heyden B, Zamdborg L, Lam D, Gooding M, Sharp GC. Autosegmentation for thoracic radiation treatment planning: A grand challenge at AAPM 2017. Med Phys. 2018 Oct; 45(10):4568-4581.
-
Johnson SB, Hung J, Kapadia N, Oh KS, Kim M, Hamstra DA. Spinal Growth Patterns After Craniospinal Irradiation in Children With Medulloblastoma. Pract Radiat Oncol. 2019 Jan; 9(1):e22-e28.
-
Lukka HR, Pugh SL, Bruner DW, Bahary JP, Lawton CAF, Efstathiou JA, Kudchadker RJ, Ponsky LE, Seaward SA, Dayes IS, Gopaul DD, Michalski JM, Delouya G, Kaplan ID, Horwitz EM, Roach M, Pinover WH, Beyer DC, Amanie JO, Sandler HM, Kachnic LA. Patient Reported Outcomes in NRG Oncology RTOG 0938, Evaluating Two Ultrahypofractionated Regimens for Prostate Cancer. Int J Radiat Oncol Biol Phys. 2018 10 01; 102(2):287-295.
-
Giantsoudi D, Adams J, MacDonald S, Paganetti H. Can differences in linear energy transfer and thus relative biological effectiveness compromise the dosimetric advantage of intensity-modulated proton therapy as compared to passively scattered proton therapy? Acta Oncol. 2018 Sep; 57(9):1259-1264.
-
Frank SJ, Blanchard P, Lee JJ, Sturgis EM, Kies MS, Machtay M, Vikram B, Garden AS, Rosenthal DI, Gunn GB, Fuller CD, Hutcheson K, Lai S, Busse PM, Lee NY, Lin A, Foote RL. Comparing Intensity-Modulated Proton Therapy With Intensity-Modulated Photon Therapy for Oropharyngeal Cancer: The Journey From Clinical Trial Concept to Activation. Semin Radiat Oncol. 2018 04; 28(2):108-113.
-
Raldow AC, Hong TS. Will There Be a Clinically Significant Role for Protons in Patients With Gastrointestinal Malignancies? Semin Radiat Oncol. 2018 04; 28(2):125-130.